Literature DB >> 9255609

VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation--evidence for divergent stabilization pathways.

F C White1, A Benehacene, J S Scheele, M Kamps.   

Abstract

Vascular Endothelial Growth Factor (VEGF) is a pivotal endothelial cell mitogen that mediates both normal and pathological angiogenesis. Although expressed at very low levels in cells not undergoing vascularization, VEGF mRNA is transiently upregulated and stabilized by a variety of extracellular stimuli, and is persistently upregulated and stabilized in many human tumor cell lines (White et al., 1995). Here we demonstrate that oncogenic activation of tyrosine protein kinases and Ras proteins induce a 6- to 16-fold increase in the abundance of VEGF mRNA and a 3- to 5-fold increase in the stability of VEGF mRNA, suggesting that persistent activation of signaling pathways induced by these oncoproteins accounts for overexpression of VEGF in a significant fraction of human tumors. In addition to these oncoproteins, ultraviolet (UV) radiation upregulated and stabilized VEGF mRNA 15- and 5-fold, respectively. While the tyrosine kinase inhibitor, genistein, blocked VEGF upregulation by activated tyrosine protein kinases, and the Ras inhibitor, N-Acetyl-S-trans-farnesyl-L-cysteine (AFC), eliminated VEGF expression in cells transformed by v-Ras, neither agent blocked upregulation by hypoxia or UV radiation. These data argue that multiple divergent pathways upregulate and stabilize VEGF mRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9255609     DOI: 10.3109/08977199709021520

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  6 in total

Review 1.  Establishing a link between oncogenes and tumor angiogenesis.

Authors:  R S Kerbel; A Viloria-Petit; F Okada; J Rak
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

Review 2.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

3.  The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis.

Authors:  Mary Ann Arndt; Valentina Battaglia; Eva Parisi; Mark J Lortie; Masato Isome; Christopher Baskerville; Donald P Pizzo; Riccardo Ientile; Sebastiano Colombatto; Antonio Toninello; Joseph Satriano
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-25       Impact factor: 4.249

4.  Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma.

Authors:  H Sasamura; A Takahashi; N Miyao; M Yanase; N Masumori; H Kitamura; N Itoh; T Tsukamoto
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

Review 5.  Angiogenesis-related pathways in the pathogenesis of ovarian cancer.

Authors:  Nikos G Gavalas; Michalis Liontos; Sofia-Paraskevi Trachana; Tina Bagratuni; Calliope Arapinis; Christine Liacos; Meletios A Dimopoulos; Aristotle Bamias
Journal:  Int J Mol Sci       Date:  2013-07-30       Impact factor: 5.923

6.  Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor.

Authors:  H Tanaka; K Nishida; K Sugita; T Yoshioka
Journal:  Jpn J Cancer Res       Date:  1999-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.